Tropicamide + PhenylephrineThird Party Manufacturing in India

Tropicamide is an antimuscarinic agent that blocks the muscarinic receptors (primarily M4) in the iris sphincter and ciliary muscle, producing mydriasis and cycloplegia. Phenylephrine is a selective α1-adrenergic agonist that directly stimulates the iris dilator muscle, enhancing pupillary dilation.

This synergistic mechanism of action helps the body achieve rapid, maximal pupillary dilation for comprehensive ophthalmic examination.

Unlike either agent used alone, the combination produces more effective and sustained mydriasis with faster onset, allowing for improved diagnostic accuracy during retinal and fundus examinations.

Therapeutic Uses

Tropicamide + Phenylephrine Ophthalmic Solution is indicated for:

• Pupillary Dilation: Induction of mydriasis for diagnostic ophthalmic procedures and fundus examination.
• Pre-operative Preparation: Dilation prior to cataract surgery and other intraocular procedures.
• Refraction: Cycloplegic refraction in pediatric and adult patients.

Why Manufacturers Choose Tropicamide + Phenylephrine

This combination is the gold standard for rapid, effective mydriasis in ophthalmic practice. The synergistic effect reduces the time required for adequate pupil dilation, improving clinical workflow efficiency.

This makes Tropicamide + Phenylephrine an essential combination product for third party manufacturing in India, serving ophthalmology clinics and hospital settings.